Manifold Bio
Tissue-targeted medicines, designed in vivo.
Manifold Bio is positioned to be the leading tissue-specific medicines company. We’ve built the first high-throughput in vivo (HTV) discovery engine - combining massively multiplexed in vivo screening and AI-powered design to create targeted biologics. Our engine sculpts pharmacokinetics, biodistribution, and other key properties of biologics directly in living systems, solving previously intractable challenges for tissue-specific delivery.
Explore similar companies to Manifold Bio
Red Queen Bio
AI-enabled biosecurity.
Bindwell
Building better pesticides with AI.
Profluent
Grounded in nature, authored by AI.
Science
A brighter tomorrow enabled by neural engineering.
Chai Discovery
Engineering better molecules using AI.
Cradle
Engineer better proteins, faster.
Lila Sciences
Building scientific superintelligence.
Valthos
Next-generation biodefense.
Convoke
AI-native OS for drug development.